Fidelity provided a $4.8m second tranche after a first close featuring vehicles for Kyushu University and Osaka University.
Existing shareholder Biohaven has agreed to purchase the remaining stake in Kleo Pharmaceuticals, a Yale spinout it first backed in 2016.
Atalanta Therapeutics has launched out of UMass with $110m in combined series A and partnership funding to develop therapies for neurodegenerative diseases.
Three years after launching to commercialise stem cell research from Harvard University, Sana has filed for an initial public offering.
USF's senior vice-president for research and innovation Paul Sanberg will return to being a distinguished professor in neurosurgery and brain repair.
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.